Literature DB >> 32917311

"Hepatic rupture in preeclampsia and HELLP syndrome: A catastrophic presentation".

Sunita Dubey1, Jyotsna Rani2.   

Abstract

The objective of index study is to review the available literature on hepatic rupture or hematoma in hypertensive disorders of pregnancy to find the incidence, associated risk factors, clinical presentation, mode of management and feto-maternal outcome. Electronic database was searched using hepatic rupture or hematoma in pregnancy, preeclampsia, eclampsia, and HELLP syndrome (Hemolysis, EL: elevated liver enzymes, LP: low platelet count) as key words and literature published since January, 2000 to December, 2018 which met the inclusion criteria was reviewed. A total of 56 articles were reviewed describing 93 cases of hepatic hemorrhage in hypertensive disorders of pregnancy. Treatment varied from conservative management to abdominal packing, hepatic artery embolization, and partial hepatectomy to liver transplantation. Seven out of 93 patients with liver rupture met mortality and in one of them diagnosis was established on autopsy. Unawareness of the hepatic rupture in pregnancy by an obstetrician demands high index of suspicion for diagnosis and requires specialized, focused and exhaustive management for optimal feto-maternal outcome. Laparotomy and perihepatic packing is a viable option in patients with unstable vitals and is feasible even in limited resource settings.Short interval between diagnosis and management may enhance the feto-maternal survival rate and prevent further morbidity or mortality.
Copyright © 2020. Published by Elsevier B.V.

Entities:  

Keywords:  Eclampsia; HELLP Syndrome; Hematoma; Hepatic rupture; Preeclampsia; pre-eclampsia

Mesh:

Year:  2020        PMID: 32917311     DOI: 10.1016/j.tjog.2020.07.003

Source DB:  PubMed          Journal:  Taiwan J Obstet Gynecol        ISSN: 1028-4559            Impact factor:   1.705


  1 in total

1.  Hypertensive disorders in pregnancy complicated by liver rupture or hematoma: a systematic review of 391 reported cases.

Authors:  Goran Augustin; Matija Hadzic; Josip Juras; Slavko Oreskovic
Journal:  World J Emerg Surg       Date:  2022-07-08       Impact factor: 8.165

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.